European Biopharmaceutical Review (EBR) is a magazine dedicated to the biopharmaceutical and biotech industries. Each quarterly edition features articles from key opinion leaders on research, drug discovery and development, biomanufacturing, outsourcing and more on the science and business of the sectors. EBR also features insightful interviews, reviews and event information to form an appealing B2B platform. Value solutions that meet national healthcare and social security budgets; Investment in innovation in Europe, bringing highly skilled employment and contributing economic benefits. Pharma and Healthcare Insight provides subscribers with analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting on global pharma and healthcare markets. The service includes online access to the very latest analysis and data, a searchable archive, and PDF access to the monthly regional Insight reports. Published by Business Monitor International, the global market specialists, Pharma and Healthcare Insight is broken down into five regional services: Asia, Western Europe, Emerging Europe, the Middle East & Africa and the Americas. For further information please view our website: www.pharmaceuticalsinsight.com or call +44 (0)20 7246 1403. Thomson Reuters is the world's leading source of authoritative content for businesses and professionals. They combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. Thomson Reuters supports the life sciences by providing the knowledge, tools and expertise to help support drug discovery and development activities. Their products and services can help you design better drugs, keep in touch with the rapidly-changing pharmaceutical and chemical markets, optimize your IP portfolio, identify licensing and partnering opportunities, stay up-to-date on worldwide regulatory requirements, and make informed, early decisions.
Lead Supporting Partner:
The PharmaTimes portfolio includes PharmaTimes Magazine for independent reporting; PharmaTimes Online www.pharmatimes.com; three free online e-news services delivered by email including World, UK and Clinical news; PharmaTimes Directors' Club, where thought-leaders meet to discuss the issues of the day; and a unique series of competitions including marketing, clinical, sales and business leadership that help industry professionals develop and hone their skills.
Supporting Partners:
BioPharm Insight is the definitive guide to the global healthcare community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.
European Pharmaceutical Review is the leading publication for information on technologies in drug discovery and manufacturing. Published bi-monthly, every issue offers a high level of technical and business contributions from the world’s leading pharmaceutical companies and academic institutions, coupled with a variety of exciting new features including interviews, updates and profiles.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. The pharmaceutical industry contributes many benefits to Europe and its citizens: Better quality healthcare and treatment choices;
Expert Opinion is a series of 12 internationally peer-reviewed journals that provide systematic and authoritative analysis to support every stage in the R&D pipeline.
With a 2012 Impact Factor range from 2.297 to 4.869 and 11 of the 12 journals MEDLINE-indexed, you can have complete confidence in the high calibre of the Expert Opinion series.
MedTech Europe is an Alliance of European medical technology industry associations. The Alliance was founded in October 2012 and currently has two members being EDMA, representing the European in vitro diagnostic industry, and Eucomed, representing the European medical devices industry. Other European medical technology associations are welcome to join the Alliance. MedTech Europe, EDMA and Eucomed remain separate entities but are led by one joint Chief Executive and work closely together on common policy interest areas.
PharmiWeb.com is the largest Pharma jobs and news portal in Europe, with thousands of jobs updated daily, and news from news from across the world.
SCRIP Intelligence provides vital original pharmaceutical industry ideas and global signals for your career, your business and your future. Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small.
Their experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight.
